FASTHEADLINENEWS

$MRK Headlines

18 trading headlines for $MRK

Apr 2 04:45 PM

Assessing Teva Pharmaceutical Industries (TEVA) Valuation After New Biosimilar Approvals And Pipeline Progress

fdaAlphaVantage

Apr 2 10:48 AM

Merck Says EU Approves KEYTRUDA, In Combination With Paclitaxel, With Or Without Bevacizumab, For Treatment Of Platinum-Resistant Epithelial Ovarian, Fallopian Tube Or Primary Peritoneal Carcinoma In Adults

commodityAlpaca

Apr 1 02:23 PM

Tempus AI Stock Jumps, ALERT Trial Results Boost EHR Automation Buzz

fdaAlpaca

Apr 1 01:26 PM

Merck Locks Infinimmune Alliance To Chase Next-Gen Antibody Drugs

fdaAlpaca

Mar 31 01:13 PM

Infinimmune Partners With Merck To Discover And Develop Therapeutic Antibodies Using Human-First AI Platform; Merck Will Have The Exclusive Right To Develop And Commercialize Antibody Candidates Arising From The Collaboration; Infinimmune Will Receive An Undisclosed Upfront Payment And Is Eligible To Receive Milestone Payments Associated With The Progress Of Multiple Antibody Candidates All Totaling Up To ~$838M

generalAlpaca

Mar 30 05:34 PM

Merck & Co., Inc. (NYSE:MRK) Receives "Outperform" Rating from Royal Bank Of Canada

analystAlphaVantage

Mar 30 05:14 PM

RBC Capital Reiterates Outperform on Merck & Co, Maintains $142 Price Target

analystAlpaca

Mar 30 04:33 PM

Newmark Group Arranges $1.65B Refinancing For One Madison Avenue

generalAlpaca

Mar 30 03:48 PM

Merck Announced Results From Third Positive Phase 3 Comparative Study On Enlicitide Decanoate When Added To Background Statins In Adults With Hypercholesterolemia Who Have A History Of Or Are At Risk For Atherosclerotic Cardiovascular Disease

fdaAlpaca

Mar 30 06:05 AM

Reported Sunday, Merck's Winrevair Demonstrates Statistically Significant 1.02 Wood Units Reduction In PVR In Phase 2 CADENCE Trial, Paving Way For Phase 3 Study

fdaAlpaca

Mar 28 04:30 PM

U.S. Hyaluronic Acid Based Dermal Fillers Market Size [2030]

generalAlphaVantage

Mar 25 03:20 PM

Merck's $6.7 Billion Terns Pharmaceuticals Acquisition May Face Rival Interest: Analyst

maAlpaca

Mar 25 11:02 AM

Citi Raises its Price Target on Merck & Co. (MRK) to $125 from $120

analystYahoo Finance

Mar 25 10:49 AM

Merck To Acquire Terns Pharma For $53.00 Per Share In Cash For Approximate Equity Value Of $6.7B

maAlpaca

Mar 25 09:38 AM

Merck Nears $6 Billion Deal To Buy Terns Pharma: Report

generalAlpaca

Mar 25 07:02 AM

'Merck Nears $6bn Biotech Deal To Boost Cancer Drug Pipeline' - FT

fdaAlpaca

Mar 24 11:38 AM

Merck Says British Columbia, NIHB, Nova Scotia, Quebec And VAC Added WINREVAIR To Their Public Drug Formularies

fdaAlpaca

Mar 24 10:18 AM

Quotient Therapeutics Enters Multi-Year Merck Deal Worth Up To $2.2B With $20M Upfront For Inflammatory Bowel Disease Drug Discovery

fdaAlpaca